Instrument Inactif

Autres langues VERMILLION INC Nasdaq

Actions

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

15/05	Transcript : Aspira Women's Health Inc., Q1 2024 Earnings Call, May 15, 2024
15/05	Aspira Women's Health Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Aspira Women’s Health Announces Preliminary Second Quarter 2024 OvaSuite Product Volume and Highlights	11/07
Aspira Women’s Health Announces Closing of $1.9 Million Private Placement Equity Financing	09/07
Aspira Women's Health Inc. announced that it has received $1.910249 million in funding	09/07
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Ahead of Powell Speech	02/07
Aspira Women’s Health Announces $1.935 Million Private Placement Equity Financing	01/07
Aspira Women's Health Inc.(NasdaqCM:AWH) added to Russell 3000E Index	01/07
Aspira Women's Health Inc.(NasdaqCM:AWH) added to Russell Microcap Index	01/07
Aspira Women's Health Inc.(NasdaqCM:AWH) added to Russell Microcap Growth Index	01/07
Aspira Women's Health Inc.(NasdaqCM:AWH) added to Russell 3000E Growth Index	01/07
Aspira Women's Health Inc. announced that it expects to receive $1.935051 million in funding	30/06
Aspira Women's Health Inc. Announces Chief Financial Officer Changes	27/06
Aspira Women’s Health Provides Commercial, Reimbursement and Cash Guidance Updates	13/06
Aspira Women’s Health to Present at the A.G.P. Healthcare Showcase on May 21	16/05
Earnings Flash (AWH) ASPIRA WOMEN'S HEALTH Reports Q1 Revenue $2.2M, vs. Street Est of $2.6M	15/05
Aspira: Q1 Earnings Snapshot	15/05
Aspira Women’s Health Reports First Quarter 2024 Financial Results	15/05
Aspira Women's Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Aspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15	08/05
Aspira Women’s Health Announces Publication of Two OvaWatch Peer-Reviewed Manuscripts	07/05
Aspira Women’s Health Enhances its Commercial Offering with the Formal Launch of Longitudinal Monitoring Feature of OvaWatch	02/05

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues VERMILLION INC Nasdaq

Actions

Autres langues

Filtres